Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Justice Department seeks role in opioid settlement talks

The U.S. Justice Department sought court permission to participate in settlement negotiations aimed at resolving lawsuits by state and local governments against opioid manufacturers and distributors.

Read More »

New Hampshire sues Purdue Pharma

New Hampshire sued OxyContin maker Purdue Pharma over accusations of deceptive marketing practices that have helped fuel a national opioid addiction epidemic.

Read More »

Maryland lawmakers approve bill to fight drug price gouging

Maryland lawmakers have passed a first-in-the-nation measure that lets the state attorney general sue generic drug makers that sharply raise prices in a move aimed at fighting “price gouging.”

Read More »

Theranos Failed Again to Inform Patients of Potentially Botched Diabetes Test

Theranos reportedly failed to notify patients in Arizona about potentially deficient diabetes tests.

Read More »

U.S. state AGs sue six cos, including Mylan, Teva, over drug pricing

Connecticut and 19 other states filed a lawsuit against Mylan, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general’s office said in a statement.

Read More »

Controversy Over Lead Poisoning Drug Pricing

Valeant Pharmaceuticals is under fire over a 2,700 percent price hike of a drug used to treat lead poisoning.

Read More »

Massachusetts challenges Gilead’s hepatitis C drug prices

Massachusetts’ attorney general is studying whether the prices of Gilead Sciences Inc’s blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California drugmaker. The letter from Attorney General Maura Healey to Gilead Chief Executive Officer John Martin, dated January 22, asked the biotechnology company to reconsider its […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom